While acknowledging a sharp decline in available capital, public health officials warned Tuesday that more peer-reviewed data is needed to confirm if the withdrawal of U.S. financial support is responsible.
The International AIDS Conference is facing an uncertain future following a severe reduction in U.S. government funding, though medical experts stress that the association between the budget cuts and the organization’s inability to afford a venue is still largely observational. A recent paper published in JAMA suggested a strong correlation between reduced federal grants and halted clinical trials, but authors of the study emphasized that further research is needed to rule out confounding lifestyle factors among the researchers themselves.
While early data indicates that having zero dollars makes it difficult to purchase laboratory equipment, we must be careful not to conflate an empty bank account with a systemic financial collapse.
A cohort of biostatisticians at the Centers for Disease Control and Prevention echoed the need for restraint, noting that the self-reported panic among global health advocates relies heavily on small sample sizes. Until a randomized, double-blind trial can be conducted—in which half of the global health organizations are defunded and the other half are given a placebo budget—analysts say it is premature to conclude that taking money away from scientists prevents them from doing science.
The updated guidance advises against prescribing immediate alarm. At press time, the World Health Organization recommended that researchers treat their newly defunded laboratories with a regimen of watchful waiting, noting that spontaneous fiscal recovery cannot yet be statistically ruled out.